The Royal Alexandra Hospital is a large and long serving hospital in the Canadian province of Alberta. Operated by Alberta Health Services and located north of Edmonton's downtown core, the Royal Alexandra serves a diverse community stretching from Downtown Edmonton to western and northern Canada.

There are 869 beds in Royal Alexandra Hospital.

During the past decade, Royal Alexandra Hospital conducted 89 clinical trials. In the 10-year time frame, 89 clinical trials started and 26 clinical trials were completed, i.e. on average, 29.2% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 11 clinical trials were completed. i.e. 36.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Alexandra Hospital" #1 sponsor was "University of Alberta" with 47 trials, followed by "University of Calgary" with 7 trials sponsored, "University of British Columbia" with 6 trials sponsored, "Abbott Medical Devices" with 4 trials sponsored and "Boehringer Ingelheim" with 4 trials sponsored. Other sponsors include 87 different institutions and companies that sponsored additional 72 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Alexandra Hospital" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 24 trials as a collaborator, "Alberta Health services" with 7 trials as a collaborator, "Alberta Innovates Health Solutions" with 5 trials as a collaborator, "Royal Alexandra Hospital" with 5 trials as a collaborator and "Canadian Critical Care Trials Group" with 4 trials as a collaborator. Other collaborators include 140 different institutions and companies that were collaborators in the rest 125 trials.

According to Clinical.Site data, the most researched conditions in "Royal Alexandra Hospital" are "Heart Failure" (12 trials), "Critical Illness" (9 trials), "Myocardial Infarction" (9 trials), "Atrial Fibrillation" (6 trials) and "Coronary Artery Disease" (4 trials). Many other conditions were trialed in "Royal Alexandra Hospital" in a lesser frequency.

Most popular intervention types in "Royal Alexandra Hospital" are "Drug" (56 trials), "Device" (34 trials), "Procedure" (34 trials), "Other" (24 trials) and "Behavioral" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Empagliflozin" (3 trials), "placebo" (3 trials), "Anti-Arrhythmic Drug Therapy" (2 trials) and "CC+SI" (2 trials). Other intervention names were less common.

The vast majority of trials in "Royal Alexandra Hospital" are 151 trials for "All" genders and 9 trials for "Female" genders.

Currently, there are 33 active trials in "Royal Alexandra Hospital". 1 are not yet recruiting, 21 are recruiting, 10 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 88 completed trials in Royal Alexandra Hospital, undefined suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Alexandra Hospital, 1 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 54 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 57 trials that are defined as “Not Applicable".